Bayer

News

Swiss hospital adopts Bayer’s AI platform for radiology

A leading Swiss teaching hospital has signed up to use Bayer’s suite of artificial intelligence-powered digital tools for X-ray, MRI, and CT imaging.

News

Bayer bets on digital to deliver ‘precision’ consumer health

Personalised and precision health is a firmly established concept in the development of new prescription medicines, but not so much in the consumer health category.

News

Boundless Bio raises $100m for circular DNA cancer therapy

Boundless Bio’s plans to develop a new class of cancer therapies targeting DNA found outside the nucleus of malignant cells have been boosted by a $100 million fundraising

News

Astellas breaks new ground in menopause with Veozah

Astellas has become the first drugmaker to bring a drug in the neurokinin 3 (NK3) receptor antagonist class to the US market, after getting FDA approval of fezolinetant fo

R&D

Bayer’s bet on CGT: Casting a wide net for innovation

With the opening of Co.Labs, Bayer's flagship coworking space for biotech start-ups in CGT, the company looks to cast a wide net for external and internal innovation in the emerging space.

News